CIK: 1803375 - Address: C/O Revance Therapeutics, Inc, 1222 Demonbreun Street, 20Th Floor, Nashville, TN 37203
6 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y

3/19/24 18:44
3/18/24
RVNCRevance Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsMoxie DwightTNOCLO,GCS-415.040-8-6138D
9/7/23 17:37
9/5/23
RVNCRevance Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsMoxie DwightTNOSVP,GC,SS.m-61317.580-35-4444D
5/16/23 20:29
5/15/23
RVNCRevance Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsMoxie DwightTNOSVP,GC,SS-73934.550-21-2469D
3/9/23 21:46
3/9/23
RVNCRevance Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsMoxie DwightTNOSVP,GC,SS-58431.590-18-2556D
9/16/22 16:55
9/14/22
RVNCRevance Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsMoxie DwightTNOSVP,GC,SS-29827.070-11-2632D
9/28/21 21:23
9/27/21
RVNCRevance Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsMoxie DwightTNOSVP,GC,SS-5030.000-2-348D

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact